Detection of tumor response to Co(III) and Fe(III) complexes by 31P-nuclear magnetic resonance spectroscopy

Experimental Oncology

Volumn 24, Issue 2, 2002, Pages 128-134

  Bubnovskaya, L N ^a   Mikhailenko, V M ^a   Kondrichin, I G ^a   Osinsky, S P ^a   Kovelskaya, A V ^a   Sigan, A L ^b   Levitin, I Ya ^b  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b A N NESMEYANOV INSTITUTE OF ORGANOELEMENT COMPOUNDS   (Russian Federation)

Author keywords

31P NMR spectroscopy; Co(III) complexes; Fe(III) complex; Guerin carcinoma

Indexed keywords

COBALT CHLORIDE; COBALT COMPLEX; IRON COMPLEX; PHOSPHORUS 31;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOENERGY; CANCER RADIOTHERAPY; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DRUG DESIGN; DRUG EFFICACY; GUERIN TUMOR; NONHUMAN; OXYGENATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREDICTION; RAT; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

EID: 0036626504     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jung M, Kerr DF, Senter PD. Bioorganometallic chemistry - synthesis and antitumor activity of cobalt carbonyl complexes. Pharmazie 1997; 330: 173-6.
2. El-Nagger MM, El-Wasser AM, El-Halafawy KM, El-Sayed IH. Antitumor activities of vanadium(IY), manganese(IY), iron(III), cobalt(II) and copper(II) complexes of 2-methylaminopyridine. Cancer Lett 1998; 133: 71-6.
3. Perin LC, Wilson WR, Denny WA, McFadyen WD. The design of cobalt(III) complexes of phenazine-1-carboxamides as prointercalators and potential hypoxia-selective cytotoxins. Anti-Cancer Drug Design 1999; 14: 231-41.
4. Daly PF, Cohen JS. Magnetic resonance spectroscopy of tumors and potential in vivo applications: a review. Cancer Res 1989; 49: 770-9.
5. 23Na, and 1h MRS studies of three models of pancreatic cancer. Cancer Res 1997; 57: 1452-9.
6. 31P NMR for non-invasive evaluation of tumor metabolic status. Int Radiat Oncol Biol Phys 1986; 12: 793-9.
7. Koutcher JA, Alfieri AA, Devitt ML, Rhee JG, Kornblith AB, Mahmood U, Merchant TE, Cowburn D. Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. Cancer Res 1992; 52: 4620-7.
8. 31P NMR spectroscopy of murine tumors before and after localized hyperthermia. Int J Hypertherm 1990; 6: 15-31.
9. 31P nuclear magnetic resonance spectroscopy: a review. Cancer Res 1989; 49: 4075-85.
10. Chapman JD, McPhee MS, Watz N, Chetner MP, Stobbe CC, Soderlind K, Arnfield M, Meelur BE, Trimble L, Allen PS. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. J Natl Cancer Inst 1991; 83: 1650-9.
11. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenografts: tumor bioenergetic status and blood supply. Br J Cancer 1993; 68: 1061-70.
12. McCoy CL, McIntyre DJO, Robinson SP, Aboagye EO, Griffiths JR. Magnetic resonance spectroscopy and imaging methods for measuring tumor and tissue oxigenation. Br J Cancer 1996; 74: S226-31.
13. 2, tension measurements in a murine fibrosarcoma. Radiat Res 1989; 120: 477-93.
14. Nielsen FU, Daugaard P, Bentzen L, Stodkidle-Jorgensen H, Overgaard J, Horsman MR, Maxwell RJ. Effect of changing tumor oxygenation on metabolism in a murine C3H mammary carcinoma assessed in vivo nuclear magnetic resonance spectroscopy. Cancer Res 2001; 61: 5318-25.
15. 31P-nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia. Cancer Res 1988; 48: 5440-6.
16. Tyagi RK, Azrad A, Degani H, Salomon Y. Simultaneous extraction of cellular lipids and water-soluble metabolites: evaluation by NMR spectroscopy. MRM 1996; 35: 194-200.
17. 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy. Int J Radiat Oncol Biol Phys 1990; 18: 1341-50.
18. 31P MRS observation of tumor energy metabolism. NMR Biomed 1992; 5: 279-89.
19. Vaupel P, Hockel M. Oxygenation of human tumors. In: Blood perfusion and microenvironment of human tumors. Molls M, Vaupel P, eds. Berlin, Heidelberg: Springer-Verlag 1998, pp, 63-72.
20. Okunieff P, Mc Farland E, Rummery E, Willett C, Hitzing B. Effects of oxygen on the metabolism of murine tumors using in vivo phosphorus-31 NMR. Am J Clin Oncol 1987; 10: 475-82.
21. 31P magnetic resonance spectroscopy: an experimental study of human melanoma xenografts. Radiother Oncol 1999; 52: 261-7.
22. Osinsky S, Levitin I, Bubnovskaya L, Sigan A, Ganusevich I, Mikhailenko V, Kovelskaya A. "Inorganic" cobalt(III) complexes with Schiff bases as new anti-cancer agents with radio/thermosensitizing activities. Exp Oncol 2000; 22 (Suppl. 2): 39-44.
23. Osinsky S, Levitin I, Bubnovskaya L, Sigan A, Ganusevich I, Mikhailenko V, Kovelskaya A. Biological activities of "inorganic" cobalt(III) complexes with tetradentate Schiff bases. Int J Med Biol Environ 2000; 28: 83-7.